chr7-141943919-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_013252.3(CLEC5A):āc.185T>Cā(p.Ile62Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000891 in 1,459,214 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_013252.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CLEC5A | NM_013252.3 | c.185T>C | p.Ile62Thr | missense_variant | 4/7 | ENST00000546910.6 | NP_037384.1 | |
CLEC5A | NM_001301167.2 | c.139+1422T>C | intron_variant | NP_001288096.1 | ||||
CLEC5A | XM_011515995.3 | c.79+2295T>C | intron_variant | XP_011514297.1 | ||||
CLEC5A | XR_007059995.1 | n.373T>C | non_coding_transcript_exon_variant | 4/8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CLEC5A | ENST00000546910.6 | c.185T>C | p.Ile62Thr | missense_variant | 4/7 | 1 | NM_013252.3 | ENSP00000449999.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000398 AC: 1AN: 251296Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135812
GnomAD4 exome AF: 0.00000891 AC: 13AN: 1459214Hom.: 0 Cov.: 28 AF XY: 0.00000551 AC XY: 4AN XY: 726030
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 16, 2024 | The c.185T>C (p.I62T) alteration is located in exon 4 (coding exon 3) of the CLEC5A gene. This alteration results from a T to C substitution at nucleotide position 185, causing the isoleucine (I) at amino acid position 62 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at